Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from a double-blind, placebo-controlled, randomized clinical trial (STEM)

Authors :: Dowsett
K. Polhlodek
Vladimir Semiglazov
JV Planellas Gomez
Jean-Michel Foidart
R. Serreyn
A. Willemsen
A. Manikhas
M. Nechushkin
Ernst Kubista
Source :: European Journal of Cancer Supplements. 4:126
Publication Year :: 2006
Publisher :: Elsevier BV, 2006.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Tibolone
Placebo
law.invention
Double blind
Randomized controlled trial
law
Internal medicine
medicine
Breast cancer cells
business
medicine.drug

Full Text Access

Tools